TGEN insider filings
TECOGEN INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-20. Screen TGEN transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 11 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 6 filings by 6 insiders — 46,500 shares, $84,714 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: purchase of 10,000 shares @ $1.96 ($19,600) by Whiting John Kimball IV, filed 2026-11-19.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Whiting John Kimball IV — General Counsel & Secretary | 2 | 1 leg · 10,000 sh · $19,600 | — | 1 |
| Lewis Earl — Director | 1 | 3 legs · 10,000 sh · $19,557 | — | — |
| Deschenes Roger P. — Chief Financial Officer | 2 | 2 legs · 10,000 sh · $17,997 | — | 1 |
| Hirsch Susan B — Director | 1 | 1 leg · 10,000 sh · $16,400 | — | — |
| Hatsopoulos John — Director | 1 | 3 legs · 5,000 sh · $8,535 | — | — |
| Rangesh Abinand — Chief Executive Officer, Director | 2 | 1 leg · 1,500 sh · $2,625 | — | 1 |
| Lafaille Stephen — VP of Business Development | 1 | — | — | 1 |
| Panora Robert — COO and President | 1 | — | — | 1 |
Recent insider filings — TECOGEN INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-20 | 4 | Hirsch Susan B — Director | Purchase (P): 10,000 @ $1.64 | EDGAR |
| 2026-11-20 | 4 | Hatsopoulos John — Director | Purchase (P): 2,000 @ $1.72 · Purchase (P): 1,000 @ $1.69 · Purchase (P): 2,000 @ $1.71 | EDGAR |
| 2026-11-20 | 4 | Rangesh Abinand — Chief Executive Officer, Director | Purchase (P): 1,500 @ $1.75 | EDGAR |
| 2026-11-19 | 4 | Lewis Earl — Director | Purchase (P): 8,094 @ $1.96 · Purchase (P): 700 @ $1.95 · Purchase (P): 1,206 @ $1.93 | EDGAR |
| 2026-11-19 | 4 | Whiting John Kimball IV — General Counsel & Secretary | Purchase (P): 10,000 @ $1.96 | EDGAR |
| 2026-11-19 | 4 | Deschenes Roger P. — Chief Financial Officer | Purchase (P): 9,700 @ $1.80 · Purchase (P): 300 @ $1.79 | EDGAR |
| 2026-09-08 | 4/A | Rangesh Abinand — Chief Executive Officer, Director | Grant/award (A): 174,081 @ $0 | EDGAR |
| 2026-09-08 | 4/A | Deschenes Roger P. — Chief Financial Officer | Grant/award (A): 29,013 @ $0 | EDGAR |
| 2026-09-08 | 4/A | Panora Robert — COO and President | Grant/award (A): 9,671 @ $0 | EDGAR |
| 2026-09-08 | 4/A | Whiting John Kimball IV — General Counsel & Secretary | Grant/award (A): 19,342 @ $0 | EDGAR |
| 2026-09-08 | 4/A | Lafaille Stephen — VP of Business Development | Grant/award (A): 29,013 @ $0 | EDGAR |
| 2026-06-30 | 4 | Whiting John Kimball IV — General Counsel & Secretary | Grant/award (A): 19,342 | EDGAR |
| 2026-06-30 | 4 | Lafaille Stephen — VP of Business Development | Grant/award (A): 29,013 | EDGAR |
| 2026-06-30 | 4 | Panora Robert — COO and President | Grant/award (A): 9,671 · Grant/award (A): 26,041 (derivative) @ $5.17 | EDGAR |
| 2026-06-30 | 4 | Rangesh Abinand — Chief Executive Officer, Director | Grant/award (A): 174,081 · Grant/award (A): 26,041 (derivative) @ $5.17 | EDGAR |
| 2026-06-30 | 4 | Hirsch Susan B — Director | Grant/award (A): 25,000 (derivative) @ $5.17 | EDGAR |
| 2026-06-30 | 4 | Ghoniem Ahmed — Director | Grant/award (A): 25,000 (derivative) @ $5.17 | EDGAR |
| 2026-06-30 | 4 | Galiteva Angelina — Director | Grant/award (A): 25,000 (derivative) @ $5.17 | EDGAR |
| 2026-06-30 | 4 | Deschenes Roger P. — CAO | Grant/award (A): 29,013 | EDGAR |
| 2026-06-30 | 4 | Lewis Earl — Director | Grant/award (A): 25,000 (derivative) @ $5.17 | EDGAR |
| 2026-06-30 | 4 | ALBERTINE JOHN M — Director | Grant/award (A): 25,000 (derivative) @ $5.17 | EDGAR |
| 2026-04-27 | 4 | Ghoniem Ahmed — Director | Purchase (P): 12,723 @ $0.79 · Option exercise (M): 12,723 (derivative) @ $0.79 | EDGAR |
| 2026-04-14 | 4 | Hirsch Susan B — Director | Purchase (P): 5,000 @ $3.73 | EDGAR |
| 2026-03-27 | 4 | Hirsch Susan B — Director | Purchase (P): 10,000 @ $2.54 | EDGAR |
| 2026-03-27 | 4 | Lewis Earl — Director | Purchase (P): 5,000 @ $2.88 | EDGAR |
| 2026-03-27 | 4 | Lewis Earl — Director | Purchase (P): 5,000 @ $2.52 | EDGAR |
| 2026-03-23 | 4 | Whiting John Kimball IV — General Counsel & Secretary | Purchase (P): 10,000 @ $2.38 | EDGAR |
| 2026-03-23 | 4 | Rangesh Abinand — Chief Executive Officer, Director | Purchase (P): 3,000 @ $2.30 | EDGAR |
| 2026-03-23 | 4 | Deschenes Roger P. — CAO | Purchase (P): 10,000 @ $2.23 | EDGAR |
| 2026-03-23 | 4 | Hatsopoulos John — Director | Option exercise (M): 50,000 @ $0.88 · Option exercise (M): 50,000 (derivative) @ $0.88 | EDGAR |
| 2025-07-28 | 4 | Lafaille Stephen — VP of Business Development | Grant/award (A): 11,976 @ $0 · Grant/award (A): 24,075 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | Whiting John Kimball IV — General Counsel & Secretary | Grant/award (A): 11,976 @ $0 · Grant/award (A): 24,075 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | Rangesh Abinand — Chief Executive Officer, Director | Grant/award (A): 53,892 @ $0 · Grant/award (A): 24,075 (derivative) @ $8.35 · Grant/award (A): 12,048 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | Hirsch Susan B — Director | Grant/award (A): 25,000 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | GHONIEM AHMED — Director | Grant/award (A): 25,000 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | GALITEVA ANGELINA — Director | Grant/award (A): 25,000 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | Deschenes Roger P. — CAO | Grant/award (A): 17,964 @ $0 · Grant/award (A): 12,063 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | LEWIS EARL R — Director | Grant/award (A): 25,000 (derivative) @ $8.35 | EDGAR |
| 2025-07-28 | 4 | ALBERTINE JOHN M — Director | Grant/award (A): 25,000 (derivative) @ $8.35 | EDGAR |
| 2025-07-14 | 4/A | PANORA ROBERT A — COO and President | Sale (S): 26,000 @ $4.69 · Sale (S): 31,000 @ $5 · Option exercise (M): 12,723 @ $0.79 · Option exercise (M): 30,000 @ $0.71 · Option exercise (M): 52,500 @ $1.10 · Sale (S): 13,000 @ $5.03 · +5 more | EDGAR |
| 2025-07-14 | 4/A | PANORA ROBERT A — COO and President | Option exercise (M): 70,000 @ $0.71 · Option exercise (M): 70,000 (derivative) @ $0.71 | EDGAR |
| 2025-06-24 | 4 | Lafaille Stephen — VP of Business Development | Purchase (P): 400 @ $2.50 · Option exercise/expiry (X): 10,000 @ $0.71 · Sale (S): 10,000 @ $4.88 · Option exercise/expiry (X): 15,000 @ $0.71 · Sale (S): 15,000 @ $5 · Option exercise/expiry (X): 25,000 @ $1.10 · +7 more | EDGAR |
| 2025-06-20 | 4 | PANORA ROBERT A — COO and President | Option exercise/expiry (X): 12,723 @ $0.79 · Option exercise/expiry (X): 30,000 @ $0.71 · Option exercise/expiry (X): 52,500 @ $1.10 | EDGAR |
| 2025-06-02 | 4 | PANORA ROBERT A — COO and President | Option exercise/expiry (X): 70,000 (derivative) @ $0.71 | EDGAR |
| 2025-05-07 | 4 | LEWIS EARL R — Director | Option exercise/expiry (X): 15,000 @ $1.75 · Option exercise/expiry (X): 12,500 @ $1.20 · Option exercise/expiry (X): 6,250 @ $1.10 | EDGAR |
| 2025-05-05 | 4 | LEWIS EARL R — Director | Other (J): 240,256 @ $2.14 | EDGAR |
| 2025-03-25 | 4/A | LEWIS EARL R — Director | Option exercise/expiry (X): 100,000 @ $0.71 · Option exercise (M): 100,000 (derivative) @ $0.71 | EDGAR |
| 2025-03-25 | 4/A | LEWIS EARL R — Director | Purchase (P): 2,000 @ $0.80 | EDGAR |
| 2025-03-25 | 4/A | LEWIS EARL R — Director | Purchase (P): 10,000 @ $0.68 | EDGAR |
| 2024-12-06 | 4 | LEWIS EARL R — Director | Purchase (P): 2,000 @ $0.80 | EDGAR |
Recent 8-K events — TECOGEN INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-05 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-18 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Registration filings — TECOGEN INC.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-212433 (S-1) — latest: Amendment (S-1/A), filed 2026-08-31
GET https://api.filingpulse.io/v1/insider-trades?ticker=TGEN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs